OBJECTIVE: There is growing evidence that vitamin D may have immunomodulatory properties in Crohn's disease (CD). The aim of this study was to determine if serum 25-hydroxy-vitamin D [25(OH)D] was associated with inflammatory cytokines, IL-10, and TNF-alpha levels in patients with inactive CD. METHODS: This was a prospective study of 75 adults with quiescent CD. Serum 25(OH)D was measured by radioimmunoassay and serum IL-10 and TNF-alpha by ELISA. Disease activity was assessed by the Crohn's disease activity index (CDAI) and C-reactive protein (CRP). RESULTS: IL-10 levels were significantly lower in patients with vitamin D insufficiency compared with the vitamin D replete group (mean and SE 2.48 ± 0.51 v 6.77 ± 2.49 pg/mL, p < 0.001). There were, however, no differences in serum TNF-alpha or CRP levels based on vitamin D status. The use of a vitamin D supplement at a low dose (200 IU) did not significantly influence IL-10 levels. CONCLUSION: Circulating levels of IL-10, but not TNF-alpha, were significantly lower in CD patients with inadequate serum 25(OH)D. This suggests that poor vitamin D status may be linked to reduced anti-inflammatory capacity in this group.
OBJECTIVE: There is growing evidence that vitamin D may have immunomodulatory properties in Crohn's disease (CD). The aim of this study was to determine if serum 25-hydroxy-vitamin D [25(OH)D] was associated with inflammatory cytokines, IL-10, and TNF-alpha levels in patients with inactive CD. METHODS: This was a prospective study of 75 adults with quiescent CD. Serum 25(OH)D was measured by radioimmunoassay and serum IL-10 and TNF-alpha by ELISA. Disease activity was assessed by the Crohn's disease activity index (CDAI) and C-reactive protein (CRP). RESULTS:IL-10 levels were significantly lower in patients with vitamin Dinsufficiency compared with the vitamin D replete group (mean and SE 2.48 ± 0.51 v 6.77 ± 2.49 pg/mL, p < 0.001). There were, however, no differences in serum TNF-alpha or CRP levels based on vitamin D status. The use of a vitamin D supplement at a low dose (200 IU) did not significantly influence IL-10 levels. CONCLUSION: Circulating levels of IL-10, but not TNF-alpha, were significantly lower in CDpatients with inadequate serum 25(OH)D. This suggests that poor vitamin D status may be linked to reduced anti-inflammatory capacity in this group.
Authors: Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Brian M Dixon; Erik D Schneider; Vanessa T Henriksen; Lindell K Weaver Journal: Eur J Appl Physiol Date: 2013-01-06 Impact factor: 3.078
Authors: Sinead N Duggan; Christina Purcell; Mark Kilbane; Myra O'Keane; Malachi McKenna; Peter Gaffney; Paul F Ridgway; Gerard Boran; Kevin C Conlon Journal: Am J Gastroenterol Date: 2015-01-27 Impact factor: 10.864
Authors: John Gubatan; Shuji Mitsuhashi; Maria Serena Longhi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss Journal: Cytokine Date: 2018-01-08 Impact factor: 3.861
Authors: Tara Raftery; Adrian R Martineau; Claire L Greiller; Subrata Ghosh; Deirdre McNamara; Kathleen Bennett; Jon Meddings; Maria O'Sullivan Journal: United European Gastroenterol J Date: 2015-06 Impact factor: 4.623
Authors: S Tony Wolf; Gabrielle A Dillon; Lacy M Alexander; Nina G Jablonski; W Larry Kenney Journal: Am J Physiol Heart Circ Physiol Date: 2022-08-05 Impact factor: 5.125
Authors: Lars E Bartels; Mia Bendix; Christian L Hvas; Søren P Jørgensen; Jørgen Agnholt; Ralf Agger; Jens F Dahlerup Journal: Inflammopharmacology Date: 2013-12-29 Impact factor: 4.473